Rechallenging with PD-1 Inhibitors: Incidence and Management of Immune-Related Adverse Events in Metastatic NSCLCT. Hoang, M. J. Elliot, C. Poletes, L. Corke, J. Weiss, M. -S. Tsao,P. Bradbury, F. A. Shepherd, G. Liu,N. Leighl,A. Sacher, S. C. M. LauJOURNAL OF THORACIC ONCOLOGY（2022）引用 0|浏览6暂无评分关键词immunotoxicity, NSCLC, PD-1 inhibitorAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
